Global injectable drug delivery market analysis, companies profiles, size, share, growth, trends and

Global Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

ReportsMonitor.com has added Global Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 to its database of market research reports.

In this region, global injectable drug delivery is projected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Download Free Sample Copy

Based on geography, the global injectable drug delivery market is segmented into 5 geographical regions, such as, North America, South America, Europe, APAC, MEA,

View Full Report

Global injectable drug delivery market competition by top players including – Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company,

Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Bespak, Antares Pharma, Elcam Medical, Haselmeier, Mylan N.V., Novo Nordisk, Owen Mumford Ltd, Sanofi, West Pharmaceutical Services, Inc, Ypsomed Holding AG.

Enquire About this Report

The global injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.

The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.

Injectable drug delivery device market is segmented into conventional injection devices and selfinjection devices.

The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.

The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.

Browse Similar Semiconductors and Electronics Market Research Reports

About Us Reports Monitor (ReportsMonitor.com) is a platform for companies looking to meet their market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. The prime focus is to get reliable data, Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.

Contact Us Jay Matthews Direct: +1 513 549-5911 Email: sales@reportsmonitor.com Website: http://www.reportsmonitor.com